Treatment of acute stroke, before a distinction can be made between ischemic and hemorrhagic types, is challenging. Whether very early blood-pressure control in the ambulance improves outcomes among ...
Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® (tenecteplase), a thrombolytic (clot-dissolving) agent, effective November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback